Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen-Reference-Cited by-同舟云学术

Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen

Published:2016-06-30 Issue:8 Volume:91 Page:819-823
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Rytting Michael E.¹²,Jabbour Elias J.²,Jorgensen Jeffrey L.³,Ravandi Farhad²,Franklin Anna R.¹,Kadia Tapan M.²,Pemmaraju Naveen²,Daver Naval G.²,Ferrajoli Alessandra²,Garcia-Manero Guillermo²,Konopleva Marina Y.²,Borthakur Gautam²,Garris Rebecca²,Wang Sa³,Pierce Sherry²,Schroeder Kurt²,Kornblau Steven M.²,Thomas Deborah A.²,Cortes Jorge E.²,O'Brien Susan M.²,Kantarjian Hagop M.²

Affiliation:

1. Pediatrics-Patient Care; the University of Texas MD Anderson Cancer Center, Texas

2. Department of Leukemia; the University of Texas MD Anderson Cancer Center, Texas

3. Department of Hematopathology; the University of Texas MD Anderson Cancer Center, Texas

Publisher

Wiley

Subject

Hematology

Reference41 articles.

1. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols?;Stock;Blood,2008

2. Should adolescents with acute lymphoblastic leukemia be treated as old children of young adults? Comparison of the French FRALLE-93 and LALA-94 trials;Boissel;J Clin Oncol,2003

3. Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials;Ramanujachar;Pediatr Blood Cancer,2007